Literature DB >> 17696792

Management strategies for acute infective conjunctivitis in primary care: a systematic review.

Peter Rose1.   

Abstract

A systematic review of the literature on all aspects of the management of acute infective conjunctivitis is undertaken. Acute infective conjunctivitis is a common presentation in primary healthcare. It is usually a mild condition and serious complications are rare. Clinical signs are a poor discriminator of bacterial and viral causes. Studies of treatment show that there is a high rate of clinical cure without any treatment (65% within 2-5 days). Treatment with topical antibiotics improves the rate of clinical recovery and this is more marked in the first 2-5 days after presentation (number needed to treat [NNT] = 6), but less by 6-10 days (NNT = 13). Studies comparing treatment with different antibiotics do not demonstrate that any one antibiotic is superior; the choice of antibiotic should be based on consideration of cost and bacterial resistance. The present practice of prescribing antibiotics to most cases is not necessary.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17696792     DOI: 10.1517/14656566.8.12.1903

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  15 in total

1.  Relative impact of clinical evidence and over-the-counter prescribing on topical antibiotic use for acute infective conjunctivitis.

Authors:  Helen Davis; David Mant; Caroline Scott; Daniel Lasserson; Peter W Rose
Journal:  Br J Gen Pract       Date:  2009-12       Impact factor: 5.386

2.  Efficacy and safety of besifloxacin ophthalmic suspension 0.6% in children and adolescents with bacterial conjunctivitis: a post hoc, subgroup analysis of three randomized, double-masked, parallel-group, multicenter clinical trials.

Authors:  Timothy L Comstock; Michael R Paterno; Dale W Usner; Michael E Pichichero
Journal:  Paediatr Drugs       Date:  2010-04-01       Impact factor: 3.022

3.  The role of topical moxifloxacin, a new antibacterial in Europe, in the treatment of bacterial conjunctivitis.

Authors:  Jose Benitez-Del-Castillo; Yves Verboven; David Stroman; Laurent Kodjikian
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

Review 4.  Moxifloxacin 0.5% ophthalmic solution: in bacterial conjunctivitis.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2011-01-01       Impact factor: 9.546

5.  Post-marketing surveillance of levofloxacin 0.5% ophthalmic solution for external ocular infections.

Authors:  Yoshiko Kanda; Tomoko Kayama; Shinji Okamoto; Masako Hashimoto; Chiemi Ishida; Tomoko Yanai; Mitsuru Fukumoto; Eiichi Kunihiro
Journal:  Drugs R D       Date:  2012-12-01

Review 6.  Levofloxacin 0.5% ophthalmic solution: a review of its use in the treatment of external ocular infections and in intraocular surgery.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2009-06-18       Impact factor: 9.546

Review 7.  Evidence-based treatment of acute infective conjunctivitis: Breaking the cycle of antibiotic prescribing.

Authors:  Kari Lee Visscher; Cindy M L Hutnik; Mary Thomas
Journal:  Can Fam Physician       Date:  2009-11       Impact factor: 3.275

8.  Clinical use of gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitis.

Authors:  Lorenzo J Cervantes; Francis S Mah
Journal:  Clin Ophthalmol       Date:  2011-04-18

9.  Impact of antibiotic resistance in the management of ocular infections: the role of current and future antibiotics.

Authors:  Joseph S Bertino
Journal:  Clin Ophthalmol       Date:  2009-09-24

10.  Besifloxacin ophthalmic suspension: emerging evidence of its therapeutic value in bacterial conjunctivitis.

Authors:  S Khimdas; K L Visscher; C M L Hutnik
Journal:  Ophthalmol Eye Dis       Date:  2011-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.